Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 04-2006 | 01-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 114 | 210 |
| Other current assets | 0 | 6 |
| TOTAL | $114 | $216 |
| Non-Current Assets | ||
| PPE Net | 1,050 | 976 |
| TOTAL | $1,050 | $976 |
| Total Assets | $1,164 | $1,192 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 28 | 27 |
| TOTAL | $28 | $27 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $28 | $27 |
| Shareholders' Equity | ||
| Common Shares | 18 | 18 |
| Retained earnings | -135 | -105 |
| TOTAL | $1,135 | $1,165 |
| Total Liabilities And Equity | $1,164 | $1,192 |